O29/279 Clinical validation trial of BraiN20(R), a medical device to predict functional recovery in patients with acute ischemic stroke undergoing endovascular thrombectomy. PROMISE20 Study Protocol

ConclusionBraiN20® could be a useful medical device to predict salvageable brain and functional recovery of patients along the stroke chain.Disclosure of InterestCo-Founder and CEO of Time is Brain S.L.
Source: Journal of NeuroInterventional Surgery - Category: Neurosurgery Authors: Tags: 3.1 OTHER - Innovation Source Type: research